LivaNova PLC (NASDAQ:LIVN) Receives Average Rating of “Buy” from Analysts

Shares of LivaNova PLC (NASDAQ:LIVN) have received an average rating of “Buy” from the seven brokerages that are currently covering the company, MarketBeat reports. One research analyst has rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating on the company. The average 1-year price objective among analysts that have covered the stock in the last year is $69.17.

LIVN has been the topic of a number of research analyst reports. Baird R W raised LivaNova from a “hold” rating to a “strong-buy” rating in a report on Tuesday, September 17th. Stifel Nicolaus raised their price objective on shares of LivaNova from $70.00 to $72.00 and gave the company a “buy” rating in a research report on Thursday, July 25th. Robert W. Baird boosted their target price on shares of LivaNova from $66.00 to $72.00 and gave the stock an “outperform” rating in a report on Thursday, October 31st. The Goldman Sachs Group started coverage on shares of LivaNova in a report on Friday, October 4th. They set a “buy” rating and a $65.00 target price for the company. Finally, Mizuho dropped their price target on LivaNova from $80.00 to $70.00 and set an “outperform” rating on the stock in a report on Thursday, October 31st.

LivaNova Stock Down 0.2 %

Shares of LIVN stock opened at $51.98 on Friday. LivaNova has a 1 year low of $42.75 and a 1 year high of $64.47. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.87 and a current ratio of 3.37. The business’s fifty day moving average is $51.31 and its 200-day moving average is $53.08. The stock has a market cap of $2.82 billion, a PE ratio of 123.76 and a beta of 1.01.

Institutional Investors Weigh In On LivaNova

Large investors have recently made changes to their positions in the company. Arizona State Retirement System boosted its stake in LivaNova by 2.0% in the 2nd quarter. Arizona State Retirement System now owns 15,104 shares of the company’s stock worth $828,000 after purchasing an additional 299 shares during the period. Atria Investments Inc lifted its holdings in shares of LivaNova by 6.2% in the third quarter. Atria Investments Inc now owns 5,653 shares of the company’s stock valued at $297,000 after purchasing an additional 331 shares in the last quarter. Fifth Third Bancorp boosted its position in shares of LivaNova by 97.1% in the second quarter. Fifth Third Bancorp now owns 674 shares of the company’s stock worth $37,000 after buying an additional 332 shares during the period. Hexagon Capital Partners LLC grew its holdings in shares of LivaNova by 117.8% during the second quarter. Hexagon Capital Partners LLC now owns 684 shares of the company’s stock valued at $37,000 after buying an additional 370 shares in the last quarter. Finally, State of Alaska Department of Revenue raised its position in LivaNova by 7.3% during the third quarter. State of Alaska Department of Revenue now owns 6,246 shares of the company’s stock valued at $328,000 after buying an additional 425 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.